Robert Glaubius

1.2k total citations
28 papers, 721 citations indexed

About

Robert Glaubius is a scholar working on Infectious Diseases, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Robert Glaubius has authored 28 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 16 papers in Epidemiology and 7 papers in Sociology and Political Science. Recurrent topics in Robert Glaubius's work include HIV/AIDS Research and Interventions (27 papers), HIV, Drug Use, Sexual Risk (15 papers) and Sex work and related issues (7 papers). Robert Glaubius is often cited by papers focused on HIV/AIDS Research and Interventions (27 papers), HIV, Drug Use, Sexual Risk (15 papers) and Sex work and related issues (7 papers). Robert Glaubius collaborates with scholars based in United States, United Kingdom and Switzerland. Robert Glaubius's co-authors include John Stover, Ume L. Abbas, Timothy B. Hallett, John W. Mellors, Andrew Phillips, Yu Teng, Séverin Guy Mahiane, Kimberly Marsh, Rowan Martin‐Hughes and Sherrie L. Kelly and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Robert Glaubius

26 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Glaubius United States 12 584 362 162 133 108 28 721
Lara Lewis South Africa 15 523 0.9× 325 0.9× 248 1.5× 120 0.9× 85 0.8× 50 774
Loveleen Bansi‐Matharu United Kingdom 13 437 0.7× 214 0.6× 104 0.6× 121 0.9× 68 0.6× 26 618
Dickman Gareta South Africa 14 462 0.8× 203 0.6× 362 2.2× 48 0.4× 139 1.3× 47 790
Chanda Mwamba Zambia 12 427 0.7× 219 0.6× 227 1.4× 59 0.4× 101 0.9× 36 671
Séverin Guy Mahiane United States 8 317 0.5× 191 0.5× 131 0.8× 38 0.3× 57 0.5× 14 683
Joseph Ouma Uganda 12 410 0.7× 153 0.4× 185 1.1× 64 0.5× 66 0.6× 25 636
Yu Teng United States 7 296 0.5× 154 0.4× 94 0.6× 53 0.4× 76 0.7× 14 434
Kristin Beima‐Sofie United States 19 804 1.4× 350 1.0× 553 3.4× 128 1.0× 61 0.6× 81 1.0k
Thu–Ha Dinh United States 17 549 0.9× 371 1.0× 374 2.3× 94 0.7× 49 0.5× 27 804
Hope Ngobese South Africa 9 315 0.5× 158 0.4× 153 0.9× 95 0.7× 55 0.5× 16 513

Countries citing papers authored by Robert Glaubius

Since Specialization
Citations

This map shows the geographic impact of Robert Glaubius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Glaubius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Glaubius more than expected).

Fields of papers citing papers by Robert Glaubius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Glaubius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Glaubius. The network helps show where Robert Glaubius may publish in the future.

Co-authorship network of co-authors of Robert Glaubius

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Glaubius. A scholar is included among the top collaborators of Robert Glaubius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Glaubius. Robert Glaubius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bansi‐Matharu, Loveleen, Daniel Citron, John Stover, et al.. (2025). Identifying gaps in the HIV treatment cascade in Africa: a model comparison study. The Lancet Global Health. 13(6). e1006–e1019. 2 indexed citations
2.
Walters, Magdalene K, Michelle A. Bulterys, Diana Louden, et al.. (2025). Probability of vertical HIV transmission: a systematic review and meta-regression. The Lancet HIV. 12(9). e638–e648.
3.
Trickey, Adam, Robert Glaubius, Cari van Schalkwyk, et al.. (2024). Excess mortality attributable to AIDS among people living with HIV in high‐income countries: a systematic review and meta‐analysis. Journal of the International AIDS Society. 27(11). e26384–e26384. 1 indexed citations
4.
Trickey, Adam, Robert Glaubius, Nikos Pantazis, et al.. (2024). Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 95(1S). e89–e96. 5 indexed citations
5.
Stover, John & Robert Glaubius. (2024). Methods and Assumptions for Estimating Key HIV Indicators in the UNAIDS Annual Estimates Process. JAIDS Journal of Acquired Immune Deficiency Syndromes. 95(1S). e5–e12. 9 indexed citations
6.
Forsythe, Steven, et al.. (2024). Estimating the costs and perceived benefits of oral pre-exposure prophylaxis (PrEP) delivery in ten counties of Kenya: a costing and a contingent valuation study. SHILAP Revista de lepidopterología. 6. 1278764–1278764. 1 indexed citations
7.
Mahiane, Séverin Guy, Jeffrey W. Eaton, Robert Glaubius, et al.. (2021). Updates to Spectrum's case surveillance and vital registration tool for HIV estimates and projections. Journal of the International AIDS Society. 24(S5). e25777–e25777. 5 indexed citations
8.
Glaubius, Robert, Sasi Jonnalagadda, Séverin Guy Mahiane, et al.. (2021). Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population‐based survey data. Journal of the International AIDS Society. 24(S5). e25784–e25784. 10 indexed citations
9.
Stover, John, Robert Glaubius, Yu Teng, et al.. (2021). Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Medicine. 18(10). e1003831–e1003831. 48 indexed citations
10.
11.
Jewell, Britta L., Edinah Mudimu, John Stover, et al.. (2020). Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. The Lancet HIV. 7(9). e629–e640. 277 indexed citations
12.
Stover, John, Robert Glaubius, Lynne Mofenson, et al.. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS. 33(Supplement 3). S227–S234. 55 indexed citations
13.
Mahiane, Séverin Guy, Kimberly Marsh, Robert Glaubius, & Jeffrey W. Eaton. (2019). Estimating and projecting the number of new HIV diagnoses and incidence in Spectrum's case surveillance and vital registration tool. AIDS. 33(Supplement 3). S245–S253. 9 indexed citations
14.
Eaton, Jeffrey W., Tim Brown, Robert Glaubius, et al.. (2019). The Estimation and Projection Package Age-Sex Model and the r-hybrid model. AIDS. 33(Supplement 3). S235–S244. 21 indexed citations
15.
Abbas, Ume L., et al.. (2019). Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study. PLoS ONE. 14(7). e0218649–e0218649. 3 indexed citations
16.
Pretorius, Carel, et al.. (2019). Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. PLoS ONE. 14(6). e0218710–e0218710. 12 indexed citations
17.
Glaubius, Robert, Greg Hood, Kerri J. Penrose, et al.. (2016). Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa. Clinical Infectious Diseases. 63(4). 539–547. 27 indexed citations
18.
Abbas, Ume L., et al.. (2013). Antiretroviral Therapy and Pre-exposure Prophylaxis: Combined Impact on HIV Transmission and Drug Resistance in South Africa. The Journal of Infectious Diseases. 208(2). 224–234. 64 indexed citations
19.
Vijver, David van de, Brooke E Nichols, Ume L. Abbas, et al.. (2013). Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa. AIDS. 27(18). 2943–2951. 53 indexed citations
20.
Vijver, David van de, Brooke E Nichols, Valentina Cambiano, et al.. (2012). Pre-exposure prophylaxis (PrEP) will have a limited impact on the prevalence of HIV-1 drug resistance in sub-Saharan Africa: comparison of mathematical models. Journal of the International AIDS Society. 15. 140–141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lara Lewis Breakdown of academic impact, for papers by Loveleen Bansi‐Matharu Breakdown of academic impact, for papers by Dickman Gareta Breakdown of academic impact, for papers by Chanda Mwamba Breakdown of academic impact, for papers by Séverin Guy Mahiane Breakdown of academic impact, for papers by Joseph Ouma Breakdown of academic impact, for papers by Yu Teng Breakdown of academic impact, for papers by Kristin Beima‐Sofie Breakdown of academic impact, for papers by Thu–Ha Dinh Breakdown of academic impact, for papers by Hope Ngobese
Rankless by CCL
2026